Varex Imaging Corporation (VREX) Stock Price, News & Analysis

Varex Imaging Corporation (NASDAQ: VREX) is a designer and manufacturer of X-ray imaging components and systems serving medical, industrial, and security markets. Classified in surgical and medical instrument manufacturing within the broader manufacturing sector, the company focuses on X-ray tubes, digital detectors, and related processing and connectivity solutions that are central to X-ray imaging systems. Its components are used in medical imaging and in industrial and security imaging applications, and it also offers X-ray imaging systems for industrial use.

According to company disclosures, Varex has a history of more than 70 years in X-ray imaging innovation. Its products are incorporated by global original equipment manufacturers (OEMs), which use Varex X-ray sources, digital detectors, connecting devices, and imaging software in their own systems. These OEM systems are used to detect, diagnose, protect, and inspect across healthcare, industrial inspection, and security screening environments.

Business Segments and Product Focus

Varex operates through two primary segments: Medical and Industrial. The Medical segment is described as the key revenue driver and provides X-ray imaging components and accessories for healthcare applications. This includes X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers, as described in third-party company summaries. These components are designed to be integrated into medical imaging systems produced by OEMs.

The Industrial segment provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Company news releases also highlight X-ray imaging systems for industrial applications, including high-energy non-intrusive cargo and vehicle inspection systems. These systems are placed at strategic locations such as sea and land ports and are used by international customers to support cargo inspection and border security.

Applications in Medical, Industrial, and Security Imaging

Varex states that its products are used in medical imaging as well as in industrial and security imaging applications. In medical imaging, OEMs integrate Varex X-ray sources and digital detectors into systems that help detect and diagnose medical conditions. In industrial and security imaging, Varex components and systems are used to protect and inspect goods and infrastructure, including cargo systems that support safe and secure ports and borders.

Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices, and imaging software into their products. These OEM relationships position Varex as a component and systems supplier rather than a direct provider of end-user imaging services. The company’s disclosures emphasize the role of its technology in enabling customers to detect, diagnose, protect, and inspect in their respective markets.

Geographic Footprint and Workforce

Varex is headquartered in Salt Lake City, Utah. Company news releases state that it employs approximately 2,300–2,400 people located in North America, Europe, and Asia. Varex Imaging Corporation generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the remainder coming from the Americas and Asia Pacific. Varex Imaging Corporation is based in the United States, and its revenue base and operations are internationally distributed.

The company’s disclosures also reference a facility in India associated with the launch of a radiographic detector, indicating operational activity in Asia in addition to its broader regional presence. However, detailed country-by-country breakdowns beyond the regions explicitly mentioned are not provided in the available information.

Financial Reporting and Segment Performance

Varex reports its results by Medical and Industrial segments in its financial communications. Recent earnings news releases describe Medical as the larger contributor to revenue, with Industrial contributing a smaller but meaningful share. The company provides both GAAP and non-GAAP metrics, including revenues, gross margin, operating margin, and segment-level revenues, and reconciles GAAP to non-GAAP measures in detailed tables.

In its fiscal year 2025 communications, Varex highlighted revenue growth driven by an improvement in the Medical segment and continued strength in the Industrial segment. Management commentary pointed to global CT tube sales in the Medical segment and momentum in cargo systems within the Industrial segment. The company also referenced non-GAAP EBITDA and non-GAAP earnings per share, while noting that certain financial results were preliminary pending the filing of its Form 10-K.

Industrial Cargo Systems and High-Energy Imaging

Multiple company news releases describe Varex’s high-energy non-intrusive cargo and vehicle inspection systems. These systems are based on high-energy Linear Accelerator (linac) imaging and are used at strategic sea and land ports by international customers. Varex’s management has characterized the company as having a strong reputation in high-energy Linear Accelerator based imaging and has emphasized its ability to integrate this technology into its own cargo systems.

Orders for these cargo inspection systems have been reported at values in the tens of millions of U.S. dollars, with references to year-to-date order totals and shipments of new systems. Company statements link these systems to efforts by customers to promote safe and secure ports and borders, positioning Varex’s Industrial segment as a contributor to security and infrastructure protection.

Research, Development, and Technology Initiatives

In its financial communications, Varex has highlighted key growth initiatives that include technologies such as photon counting for CT and the launch of a radiographic detector from a facility in India. The company’s financial statements show research and development expenses as a recurring operating line item, indicating ongoing investment in product development and technology.

While detailed technical specifications are not provided in the available materials, the company’s description of itself as an innovator, designer, and manufacturer of X-ray imaging components and systems, combined with references to photon counting for CT and radiographic detector launches, underscores a focus on advancing imaging technology within its core markets.

Capital Structure and Public Company Status

Varex Imaging Corporation’s common stock trades on the Nasdaq under the ticker symbol VREX. The company files periodic and current reports with the U.S. Securities and Exchange Commission (SEC), including Forms 10-K, 10-Q, and 8-K. Recent 8-K filings include the furnishing of earnings press releases and disclosures related to executive transitions.

The company has referenced convertible notes and senior secured notes in its financial communications, including plans to repay the outstanding principal of convertible notes upon maturity and the existence of restricted cash related to a senior secured note add-on. Balance sheet disclosures show long-term debt and current maturities of long-term debt as part of its capital structure.

Management and Governance Developments

An 8-K filing dated September 11, 2025, describes a transition agreement with the company’s Senior Vice President, Chief Legal Officer, and Corporate Secretary. Under this agreement, the executive continues as Chief Legal Officer through a specified transition period and then provides transition services as a non-executive employee or advisor through a defined continued service period. The filing details compensation, benefits, equity vesting treatment, and other customary terms, as well as the company’s ability to terminate the agreement for cause.

This type of disclosure illustrates Varex’s reporting of changes in key officer roles and related compensatory arrangements, as required under SEC rules.

Revenue Mix and Regional Exposure

Varex generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific. In addition, company earnings releases discuss demand trends in specific markets such as China, including the impact of tariffs on China-based customers and the effect on sales outlooks.

These disclosures suggest that Varex’s revenue base is diversified across regions, with particular importance placed on EMEA and on dynamics affecting customers in China. However, the available information does not provide detailed country-level revenue breakdowns beyond these regional references.

Stock Titan Overview for VREX

On Stock Titan’s overview page for VREX stock, investors can use this description as a starting point to understand Varex Imaging Corporation’s role as a manufacturer of X-ray imaging components and systems for medical, industrial, and security applications. The company’s two-segment structure (Medical and Industrial), its global OEM customer base, and its presence in cargo inspection systems and advanced imaging technologies such as photon counting for CT are central to its profile.

For a fuller picture, users typically combine this qualitative overview with the company’s own SEC filings, earnings releases, and other official disclosures, which provide detailed financial and operational information.